<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: institute of health</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'institute of health'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22institute+of+health%22&t=%22institute+of+health%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:22:27 +0100</lastBuildDate>
        <item>
            <title>Introducing Adventures in Positive Psychology</title>
            <link>http://www.medworm.com/index.php?rid=4399618&amp;cid=t_155306_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F01%2F25%2Fintroducing-adventures-in-positive-psychology%2F</link>
            <description>I&amp;#8217;m pleased to introduce our newest blog, Adventures in Positive Psychology with Joe Wilner, MA, focused on the topic of positive psychology. You’ve probably heard a thing or two about positive psychology in the past decade, because of its focus on helping people to better understand themselves and their lives to increase happiness. Sure, life can be challenging sometimes and many face a mental health concern. But that’s no reason you shouldn’t be seeking personal growth all of your life too, and find ways to increase your happiness and well-being.
Joe Wilner has a Masters Degree in Psychology and a Masters in Liberal Arts, with a concentration in Management and Leadership. Joe is a certified meditation instructor through the American Institute of Health Care Professionals (AIH...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4399618</comments>
            <pubDate>Tue, 25 Jan 2011 20:55:40 +0100</pubDate>
            <guid isPermaLink="false">4399618</guid>        </item>
        <item>
            <title>The ONC Interoperability Framework</title>
            <link>http://www.medworm.com/index.php?rid=3420588&amp;cid=t_155306_113_f&amp;fid=38236&amp;url=http%3A%2F%2Fwww.healthcareitnews.com%2Fblog%2Fonc-interoperability-framework</link>
            <description>In my summary of the March HIT Standards Committee meeting I mentioned the new ONC Interoperability Framework and the related RFPs. Here's the detail I promised in my previous blog about ONC. Thanks to Doug Fridsma for this overview and his hard work on it.
ONC announced several projects to support Standards and Interoperability Framework and Nationwide Health Information Network (NHIN). (Source: Healthcare IT News Blog)</description>
            <author>Healthcare IT News Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3420588</comments>
            <pubDate>Tue, 30 Mar 2010 13:16:41 +0100</pubDate>
            <guid isPermaLink="false">3420588</guid>        </item>
        <item>
            <title>Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories and Clinical Data</title>
            <link>http://www.medworm.com/index.php?rid=2989365&amp;cid=t_155306_136_f&amp;fid=36162&amp;url=http%3A%2F%2Fwww.myelomablog.com%2F2009%2F11%2F12%2Fadvancing-rare-disease-research-the-intersection-of-patient-registries-biospecimen-repositories-and-clinical-data%2F</link>
            <description>Subject: Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories and Clinical Data
The Office of Rare Diseases Research, National Institute of Health, is sponsoring a workshop entitled &amp;#8220;Advancing Rare Disease Research: The Intersection of Patient Registries, Biospecimen Repositories and Clinical Data,&amp;#8221; which will be held in the DoubleTree Hotel in Bethesda, Maryland, on January 11-12, 2010.
The workshop objective is to discuss the development of an infrastructure for an internet-based platform with common data elements utilizing a federated rare disease registry able to incorporate:
1.   Existing rare disease registries
2.   Patient organizations with no registry looking to establish one
3.   Patients with no affiliation with a support ...</description>
            <author>beth's myeloma blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2989365</comments>
            <pubDate>Thu, 12 Nov 2009 18:00:09 +0100</pubDate>
            <guid isPermaLink="false">2989365</guid>        </item>
        <item>
            <title>Rare Disease Research Gets NIH Funding</title>
            <link>http://www.medworm.com/index.php?rid=2441253&amp;cid=t_155306_87_f&amp;fid=34872&amp;url=http%3A%2F%2Fwww.blisstree.com%2Fhealthbolt%2Frare-disease-research-gets-nih-funding%2F</link>
            <description>Drug companies are always keen to get on the bandwagon when it comes to diseases that affect millions. Makes sense, I guess. After all, when you running a business, you want to create product that will be used by the masses.
Unfortunately, that leaves a lot of rare and neglected diseases (around 6,000 according to the NIH) under researched and under treated because they only occur in a small percentage of the population.
The National Institute of Health (NIH) is hoping to change this with a influx of funds - to the tune of $120 million over five years - through a new program called Therapeutics for Rare and Neglected Diseases (TRND)
This program has been set up to support and encourage researchers in government, academic, and companies to focus on the often called ‘orphan diseases.’
Bu...</description>
            <author>Healthbolt</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2441253</comments>
            <pubDate>Thu, 28 May 2009 01:47:49 +0100</pubDate>
            <guid isPermaLink="false">2441253</guid>        </item>
        <item>
            <title>UK Disputes Value Of Celgene Cancer Med</title>
            <link>http://www.medworm.com/index.php?rid=1918201&amp;cid=t_155306_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F434593179%2F</link>
            <description>Revlimid can extend the lives of patients with an aggressive cancer of the bone marrow by up to three years, but draft guidance from the UK&amp;#8217;s National Institute of Health and Clinical Excellence has said it is not cost effective and the estimate of three years of extra life was disputed, The Telegraph reports. 
The med is used to treat Myeloma, an incurable bone marrow cancer that cuts production of red and white blood cells. An estimated 20,000 people in the UK have the disease and each year around 3,800 new cases are diagnosed. The cancer has a high mortality rate, claiming more than 2,400 lives a year. But Revlimid costs $56,400 per patient per year and breaches the cost effectiveness threshold used by NICE more than twice over, the paper writes. 
Charities are now calling for the...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1918201</comments>
            <pubDate>Tue, 28 Oct 2008 10:41:24 +0100</pubDate>
            <guid isPermaLink="false">1918201</guid>        </item>
        <item>
            <title>NCI Board Nixes Pharma Plan To Fund Research</title>
            <link>http://www.medworm.com/index.php?rid=1551894&amp;cid=t_155306_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F321589313%2F</link>
            <description>A research program shot down by National Cancer Institute scientific advisors earlier this week was unlike any other, according to The Cancer Letter. The NCI proposed using $5 million in pharmaceutical industry money to pay for up to three R01 (investigator-inititated) grants to study the tumor promotion potential the ESA drugs, which are sold by Amgen and Johnson &amp;#038; Johnson.
And the money would be contributed by those same companies, and floated through the Foundation for the National Institutes of Health, which the newsletter notes is a non-profit created by Congress to raise private funds to help support biomedical research.
Confronted with the proposal for a Request for Applications at its June 23 meeting, members of the NCI scientific advisory board were troubled by the ethics of ...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1551894</comments>
            <pubDate>Sat, 28 Jun 2008 00:41:34 +0100</pubDate>
            <guid isPermaLink="false">1551894</guid>        </item>
        <item>
            <title>New Function Of Hemoglobin To Aid In Cardiovascular Disease</title>
            <link>http://www.medworm.com/index.php?rid=1005311&amp;cid=t_155306_111_f&amp;fid=36048&amp;url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAHeartyLife%2F%7E3%2F180327808%2F</link>
            <description>Pretty big stuff to report. Researchers out of Wake Forest, National Institute of Health as well as other institutions have discovered a previously undetected chemical process within the oxygen carrying molecule hemoglobin that could have huge implications for cardiovascular disease. Just what does hemoglobin do anyway?
In the bloodstream, iron-rich hemoglobin consumes, on contact, any free nitric oxide released by the blood vessels, so the idea that hemoglobin participates in forming nitric oxide had seemed implausible until recently.
Basically&amp;#8230;hemoglobin is the iron rich oxygen transport protein in the red blood cells. That is the easiest way I know to explain it but you could always Google if you feel the need, haha.
But seriously, this new implication for this mighty little molec...</description>
            <author>A Hearty Life</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1005311</comments>
            <pubDate>Tue, 06 Nov 2007 01:57:08 +0100</pubDate>
            <guid isPermaLink="false">1005311</guid>        </item>
        <item>
            <title>Taking care of women's hearts</title>
            <link>http://www.medworm.com/index.php?rid=2510399&amp;cid=t_155306_87_f&amp;fid=34866&amp;url=http%3A%2F%2Fwww.thecardioblog.com%2F2007%2F09%2F14%2Ftaking-care-of-womens-hearts%2F</link>
            <description>Filed under: Heart Centers Online, Research, Women Heart HealthAs you may know, The Cardio Blog is being retired today. It's been an honor to write for this blog, and I hope that the information we brought to you was useful and informative. Since this will be my last post for The Cardio Blog, I thought I'd write about a topic that is near and dear to my heart (pun, lamely, intended): women's heart health. We've seen it in the headlines again and again -- women, and often their doctors, don't always prioritize their health, and this seems to be especially an issue when it comes to heart health. But the fact is that heart disease is public enemy number one for women, and we all need to better understand and deal with our risk factors.So I'll leave you with this post from Her Daily News. In i...</description>
            <author>The Cardio Blog</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2510399</comments>
            <pubDate>Thu, 13 Sep 2007 23:00:00 +0100</pubDate>
            <guid isPermaLink="false">2510399</guid>        </item>
    </channel>
</rss>

